Drag a card by its title · ⚙ to size, swap or remove

The company

Contineum Therapeutics, Inc.

CTNM · Nasdaq

Health CareBiotechnologyNot moving yet

CTNM stood above a rising 150-day average in 43 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 48.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 5
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $3.6M
Officials’ trades on record: 0
Institutions holding: 102 (+16)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 43 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months26

Buyers · sellers0 · 3

Who	Did	Shares	Traded
Carmine N. StengoneCEO and President	sold	2,500at $16.46	8 Sep 2026filed 8 Sep 2026
Carmine N. StengoneCEO and President	sold	2,500at $16.01	3 Aug 2026filed 3 Aug 2026
Daniel S. LorrainChief Scientific Officer	sold	25at $16.00	9 Jul 2026filed 10 Jul 2026
Carmine N. StengoneCEO and President	sold	2,500at $16.00	8 Jul 2026filed 8 Jul 2026
Daniel S. LorrainChief Scientific Officer	sold	1,015at $16.00	8 Jul 2026filed 10 Jul 2026
Daniel S. LorrainChief Scientific Officer	sold	5,852at $15.67	1 Jul 2026filed 2 Jul 2026
Daniel S. LorrainChief Scientific Officer	sold	2,501at $16.24	1 Jul 2026filed 2 Jul 2026
Carmine N. StengoneCEO and President	sold	10,000at $16.01	30 Jun 2026filed 1 Jul 2026
Tim WatkinsCMO & Head of Development	sold	10,833at $16.02	30 Jun 2026filed 1 Jul 2026
Daniel S. LorrainChief Scientific Officer	sold	28,826at $16.04	30 Jun 2026filed 2 Jul 2026
Daniel S. LorrainChief Scientific Officer	sold	4,170at $13.16	1 Jun 2026filed 1 Jun 2026
Daniel S. LorrainChief Scientific Officer	sold	3,870at $13.06	1 May 2026filed 1 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders102+16 on the quarter

New · exited31 · 15

Reported value$503.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
MONTANOVA CAPITAL, LLCunchanged · filed 14 Aug 2026	2,841,334$46.6M	00.0%
Jupiter Topco LLCnew · filed 14 Aug 2026	2,734,836$44.8M	+2,734,836
BlackRock, Inc.added · filed 7 Aug 2026	2,064,345$33.8M	+1,395,222+208.5%
JOHNSON & JOHNSONunchanged · filed 6 Aug 2026	1,979,173$32.4M	00.0%
FRANKLIN RESOURCES INCunchanged · filed 13 Aug 2026	1,839,227$30.1M	00.0%
Balyasny Asset Management L.P.reduced · filed 14 Aug 2026	1,522,793$25.0M	-162,842−9.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,321,356$21.7M	+107,183+8.8%
PERCEPTIVE ADVISORS LLCunchanged · filed 14 Aug 2026	1,255,592$20.6M	00.0%
FMR LLCadded · filed 13 Aug 2026	1,040,130$17.0M	+225,259+27.6%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026	931,709$15.3M	-603,740−39.3%